期刊文献+

48例阿托伐他汀不良反应文献分析 被引量:6

Analysis of 48 Cases of Atorvastatin Induced Adverse Reactions
原文传递
导出
摘要 目的:分析阿托伐他汀不良反应的发生特点和临床表现,为临床合理应用提供参考。方法:检索和分析中国知网中国医院知识总库(CHKD)期刊全文数据库中2001~2014年阿托伐他汀不良反应。对患者性别、年龄、用药剂量、ADR发生时间、原发疾病及不良反应表现等进行统计分析。结果:共检索出47篇文献,48例。其中51~60岁患者不良反应发生较多;每日用药20 mg不良反应发生较多;不良反应累及器官以骨骼肌肉系统为主。结论:在临床应用过程中,应注意阿托伐他汀的不良反应,确保患者用药安全。 Objective: To analyze the clinical manifestations and characteristics of atorvastatin induced adverse reactions, so as to provide references for the clinical reasonable application of atorvastatin. Methods : Atorvastatin induced adverse reactions reported in the journal full-text database of China hospital knowledge database (CHKD) from 2000 to 2014 were reviewed. The patients' gender, age, dosage, ADR time of occurrence, the primary disease and adverse drug reactions were analyzed statistically. Results :48 cases reported in 47 literatures were reviewed, most ADR cases were found in 51-60 years old patients and the patients with the daily dose of 20 mg; musculoskeletal system was mostly involved in these ADR cases. Conclusion:In the clinical application of atorvastatin, more attentions should be paid to the atorvastatin induced adverse effects to ensure the safety medication.
机构地区 北京医院药学部
出处 《药物流行病学杂志》 CAS 2015年第9期562-565,共4页 Chinese Journal of Pharmacoepidemiology
关键词 阿托伐他汀 药品不良反应 横纹肌溶解症 文献分析 Atorvastatin Adversedrng drug reactions Rhabdomyolysis Literature analysis
  • 相关文献

参考文献9

  • 1Athyros Vot, Tziomalos K, Karagiannis A, et al. Atorvasta- tin : safety and tolerability[ J]. Expert Opin Drug Saf,2010,9 (4) :667-674.
  • 2Arca M. Atorvastatin: A safety and tolerability profile [ J ]. Drugs,2007,67( suppl 1 ) :63-69.
  • 3药品不良反应报告和监测管理办法[s].卫生部81号令.2011.
  • 4Sakaeda T, Kadoyama K, Okuno Y. Statin-associated mut cular and renal adverse events:data mining of the public vet sion of the FDA adverse event reporting system [ J ]. PlOne ,2011,6(12) : e28-124.
  • 5翟静,李军明,张爱兰.辅酶Q10在他汀类药物应用中的保护作用[J].泰山医学院学报,2009,30(9):725-728. 被引量:7
  • 6仝其广,胡大一.他汀类药物的安全性问题[J].中国实用内科杂志,2007,27(9):655-657. 被引量:64
  • 7注意他汀对认知功能的不良反应[J].中华高血压杂志,2008,16(7):669-669. 被引量:2
  • 8CFDA.药物警戒快讯(2012年第3期)[EB/OL].http://www.sda.gov.cn/WS01/CL0389/72166.html./2015-01-31.
  • 9CFDA.药品不良反应信息通报(第5l期):警惕他汀类药品血糖异常不良反应及与HIV蛋白酶抑制剂的相互作用.http://www.sda.gov.cn/WS01/CL0078/75600.html./2015.02-02.

二级参考文献22

  • 1由春娜,芮伟,翟所迪.他汀类药物安全性及其在特定疾病人群中的应用[J].世界临床药物,2004,25(10):611-617. 被引量:7
  • 2Sever PS,Dahl of B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentration,in the angi o-scandinavian carsdic outcomes trial-lipid-lowering arm (ASCOT-LLA):a multicentre randomized controlled trial[J].Lancet,2003,361:1149-2258.
  • 3Mellors A,Tappel A L.The inhibition of mitochondrial peroxidation by ubiquinone and ubiquinol[J].J Biol Chern,1966,241:4353-4356.
  • 4Moride Y,Hegele RA,Langer A,et al.Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events:resolved and unresolved issue[J].Can J Cardiol,2008,24 (4):293-300.
  • 5Vasa M,Fichtlscheres S.Increaes in circulating endothelial progenitor cells by statin therapy in patients with stable cororary artery disease[J].Circulation,2001,103 (9):2885-2890.
  • 6Amorose G,Van Veldhuisen DJ,Tio RA,et al.Pathophysiology of vascular endothelium and circulation platelets:Implications for coronary revasculavisation and treatmet[J].Int J Cardiol,2001,79(223):265-275.
  • 7Wassmann S,Lau fs U,Baumer AT.Inhibition of gerannylgeranylation reduces angiotensin Ⅱ mediated free radical production in vascular smooth cells:involvment of angiotensin AT I recepfor expression and Racl GTP ase[J].Mol Pharmcol,2001,59(3):646-654.
  • 8Walker JL,Smith GH,Gaston MS,et al.Spontaneous compartment syndrome in association with simvastatin-induced myositis[J].Emerg Med J,2008,25 (5):305-306.
  • 9Crane FL.Biochehaeal functions of coenzyme Q10.J AM Coll Nutr,2001,20(6):591-598.
  • 10Young XY,Jabbour S,Goldberg R,et al.Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease[J].Am J Cardiol,2003,92:1379 -1383.

共引文献70

同被引文献79

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部